Dr. French is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis Street Amory 3
Brigham And Womens Hospital Department Of Pathology
Boston, MA 02115Phone+1 617-732-7510
Education & Training
Brigham and Women's HospitalFellowship, Cytopathology, 1998 - 1999- Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 1995 - 1998
Columbia University Vagelos College of Physicians and SurgeonsClass of 1995
Certifications & Licensure
MA State Medical License 1999 - 2026
American Board of Pathology Anatomic Pathology- American Board of Pathology Cytopathology
Publications & Presentations
PubMed
- Hiding in plain sight: NUT carcinoma is an unrecognized subtype of squamous cell carcinoma of the lungs and head and neck.Jia Luo, Justin A Bishop, Steven G DuBois, Glenn J Hanna, Lynette M Sholl
Nature Reviews. Clinical Oncology. 2025-04-01 - Primary cutaneous NUT adnexal carcinoma: morphologic, genetic and methylation analysis of seven new cases with comparison to extracutaneous NUT carcinoma and NUTM1-rea...Mélanie Legrand, Baptiste Louveau, Amélie Osio, Anne Tallet, Eduardo Calonje
Histopathology. 2025-03-24 - MAD::NUT Fusion Sarcoma: A Sarcoma Class With NUTM1, NUTM2A, and NUTM2G Fusions and Possibly Distinctive Subtypes.David J Papke Jr, John S A Chrisinger, Christopher A French, Anthony Crymes, Thomas C Krivak
Modern Pathology. 2025-02-06
Journal Articles
- CIC‐NUTM1 Fusion: A Case Which Expands the Spectrum of NUT‐Rearranged Epithelioid MalignanciesGlenn J Hanna, Christopher A French, Genes, Chromosomes and Cancer
Grant Support
- Overcoming Limitations of BETInhibition in NUT CarcinomaBRIGHAM AND WOMEN'S HOSPITAL2024–2029
- Overcoming Limitations of BETInhibition in NUT CarcinomaBRIGHAM AND WOMEN'S HOSPITAL2024–2029
- Genetically engineered mouse model to improve therapy of NUT carcinomaBRIGHAM AND WOMEN'S HOSPITAL2023–2028
- Genetically engineered mouse model to improve therapy of NUT carcinomaBRIGHAM AND WOMEN'S HOSPITAL2023–2028
- Pathogenesis and Treatment of NUT midline carcinomaBRIGHAM AND WOMEN'S HOSPITAL2007–2028
- IQGAP1 In Microbial PathogenesisNational Institute Of Allergy And Infectious Diseases2010
- T(15;19) In Aggressive Pediatric CarcinomaNational Cancer Institute2002–2006
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
